Drug Shortage Report for VIBERZI
Report ID | 168058 |
Drug Identification Number | 02460890 |
Brand name | VIBERZI |
Common or Proper name | Viberzi (Eluxadoline Tablets) |
Company Name | ALLERGAN INC |
Market Status | MARKETED |
Active Ingredient(s) | ELUXADOLINE |
Strength(s) | 75MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 60s |
ATC code | A07DA |
ATC description | |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2022-07-01 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-09-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | Yes |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2022-09-22 | English | Compare |
v2 | 2022-08-26 | French | Compare |
v1 | 2022-08-26 | English | Compare |
Showing 1 to 3 of 3